Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs

被引:19
|
作者
Jin, Haolun [1 ]
Wright, Matthew [1 ]
Pastor, Richard [1 ]
Mish, Michael [1 ]
Metobo, Sammy [1 ]
Jabri, Salman [1 ]
Lansdown, Rachael [1 ]
Cai, Ruby [1 ]
Pyun, Peter [1 ]
Tsiang, Manuel [1 ]
Chen, Xiaowu [1 ]
Kim, Choung U. [1 ]
机构
[1] Gilead Sci Inc, Dept Med Chem, Foster City, CA 94404 USA
关键词
D O I
10.1016/j.bmcl.2008.01.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of C5-aza tricyclic HIV integrase inhibitors was prepared. A highly potent and orally bioavailable compound ( compound 9) was identified and selected for development. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1388 / 1391
页数:4
相关论文
共 50 条
  • [31] Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors
    Chan, L
    Stefanac, T
    Turcotte, N
    Hu, ZH
    Chen, YM
    Bédard, J
    May, S
    Jin, HL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) : 1477 - 1480
  • [32] Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
    Augeri, DJ
    Janowick, D
    Kalvin, D
    Sullivan, G
    Larsen, J
    Dickman, D
    Ding, H
    Cohen, J
    Lee, J
    Warner, R
    Kovar, P
    Cherian, S
    Saeed, B
    Zhang, HC
    Tahir, S
    Ng, SC
    Sham, H
    Rosenberg, SH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (08) : 1069 - 1074
  • [33] Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication
    Skerlj, Renato
    Bridger, Gary
    Zhou, Yuanxi
    Bourque, Elyse
    McEachern, Ernest
    Danthi, Sanjay
    Langille, Jonathan
    Harwig, Curtis
    Veale, Duane
    Carpenter, Bryon
    Ba, Tuya
    Bey, Michael
    Baird, Ian
    Wilson, Trevor
    Metz, Markus
    MacFarland, Ron
    Mosi, Renee
    Bodart, Veronique
    Wong, Rebecca
    Fricker, Simon
    Huskens, Dana
    Schols, Dominique
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (03): : 216 - 221
  • [34] Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
    Ruebsam, Frank
    Murphy, Douglas E.
    Tran, Chinh V.
    Li, Lian-Sheng
    Zhao, Jingjing
    Dragovich, Peter S.
    McGuire, Helen M.
    Xiang, Alan X.
    Sun, Zhongxiang
    Ayida, Benjamin K.
    Blazel, Julie K.
    Kim, Sun Hee
    Zhou, Yuefen
    Han, Qing
    Kissinger, Charles R.
    Webber, Stephen E.
    Showalter, Richard E.
    Shah, Amit M.
    Tsan, Mei
    Patel, Rupal A.
    Thompson, Peggy A.
    LeBrun, Laurie A.
    Hou, Huiying J.
    Kamran, Ruhi
    Sergeeva, Maria V.
    Bartkowski, Darian M.
    Nolan, Thomas G.
    Norris, Daniel A.
    Khandurina, Julia
    Brooks, Jennifer
    Okamoto, Ellen
    Kirkovsky, Leo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (22) : 6404 - 6412
  • [35] Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors
    Elsayed, Mohamed S. A.
    Blake, James F.
    Boys, Mark L.
    Brown, Eric
    Chapsal, Bruno D.
    Chicarelli, Mark J.
    Cook, Adam W.
    Fell, Jay B.
    Fischer, John P.
    Hanson, Lauren
    Lemieux, Christine
    Martinson, Matthew C.
    McCown, Joseph
    McNulty, Oren T.
    Mejia, Macedonio J.
    Neitzel, Nickolas A.
    Otten, Jennifer N.
    Rodriguez, Martha E.
    Wilcox, Daniel
    Wong, Christina E.
    Zhou, Yeyun
    Hinklin, Ronald J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (12): : 1673 - 1681
  • [36] POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS CONTAINING NONCODED D-AMINO ACIDS
    MUNROE, JE
    SHEPHERD, TA
    JUNGHEIM, LN
    HORNBACK, WJ
    HATCH, SD
    MUESING, MA
    WISKERCHEN, MA
    SU, KS
    CAMPANALE, KM
    BAXTER, AJ
    COLACINO, JM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (23) : 2897 - 2902
  • [37] Allosteric inhibitors of hepatitis C polymerase: Discovery of potent and orally bioavailable carbon-linked dihydropyrones
    Li, Hui
    Linton, Angelica
    Tatlock, John
    Gonzalez, Javier
    Borchardt, Allen
    Abreo, Mel
    Jewell, Tanya
    Patel, Leena
    Drowns, Matthew
    Ludlum, Sarah
    Goble, Mike
    Yang, Michele
    Blazel, Julie
    Rahavendran, Ravi
    Skor, Heather
    Shi, Stephanie
    Lewis, Cristina
    Fuhrman, Shella
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) : 3969 - 3972
  • [38] Discovery of potent and orally active tricyclic-based FBPase inhibitors
    Tsukada, Tomoharu
    Kanno, Osamu
    Yamane, Takahiro
    Tanaka, Jun
    Yoshida, Taishi
    Okuno, Akira
    Shiiki, Takeshi
    Takahashi, Mizuki
    Nishi, Takahide
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5346 - 5351
  • [39] Effect of substitution on novel tricyclic HIV-1 integrase inhibitors
    Fardis, Maria
    Jin, Haolun
    Jabri, Salman
    Cai, Ruby Z.
    Mish, Michael
    Tsiang, Manuel
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 4031 - 4035
  • [40] Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors
    Qin, Donghui
    Lin, Xiaojuan
    Liu, Zhi
    Chen, Yan
    Zhang, Zhiliu
    Wu, Chengde
    Liu, Linlin
    Pan, Yan
    Laquerre, Sylvie
    Emery, John
    Fergusson, Jeff
    Roland, Kimberly
    Keenan, Rick
    Oliff, Allen
    Kumar, Sanjay
    Cheung, Mui
    Su, Dai-Shi
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (06): : 1005 - 1010